Purdue Pharma Settlement: $7.4 Billion for Opioid Crisis Recovery

Purdue Pharma and the Sackler families have agreed to a $7.4 billion settlement to resolve lawsuits accusing them of fueling the U.S. opioid epidemic through OxyContin's aggressive marketing. The funds, distributed over 15 years, will support addiction treatment, prevention programs, and recovery efforts in communities heavily affected by the crisis. Unlike previous deals, the Sacklers will no longer have liability protections, opening them to future lawsuits. Purdue Pharma will also operate under new management and is prohibited from marketing opioids, setting a precedent for corporate accountability in public health crises. For detailed insights, visit https://issueinside.blogspot.com/2025/01/purdue-pharmas-74-billion-opioid.html

Purdue Pharma’s $7.4 Billion Opioid Settlement Explained